{"created":"2021-03-01T06:16:48.158650+00:00","id":12522,"links":{},"metadata":{"_buckets":{"deposit":"0c19fcc4-f433-4aa8-8a37-d3678ed69c7e"},"_deposit":{"id":"12522","owners":[],"pid":{"revision_id":0,"type":"depid","value":"12522"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00012522","sets":["453:456","471:537:538:1026"]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2005-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"6","bibliographicPageEnd":"367","bibliographicPageStart":"367","bibliographicVolumeNumber":"119","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"1.CYP450による誘導の代表とされるrifampicin 450mg/day一年間投与を経験し,治療域に維持するwarfarin一週間投与量(w/week)が過去10.6年の7.36±0.6mgに対し,31.7±0.49mgと4.3倍に達するのを見た.2.抗脂質血症治療剤であるprobucol投与の44名では維持量は数ヶ月単位で漸増し,また投与中止後でも維持量が数ヶ月単位で漸減した.dihydropyridine系Ca拮抗剤はこれと拮抗し,また動脈塞栓や脳梗塞の予防効果がなく,凝固能亢進が疑われた.","subitem_description_type":"Abstract"}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"真島, 正"}],"nameIdentifiers":[{"nameIdentifier":"83516","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-07"}],"displaytype":"detail","filename":"KJ00004300242.pdf","filesize":[{"value":"625.2 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"KJ00004300242.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/12522/files/KJ00004300242.pdf"},"version_id":"4a9855d3-48fc-4622-877a-6b4e520eb0ab"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)"},{"subitem_title":"5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1026"],"pubdate":{"attribute_name":"公開日","attribute_value":"2007-05-10"},"publish_date":"2007-05-10","publish_status":"0","recid":"12522","relation_version_is_last":true,"title":["5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:45:20.738884+00:00"}